Ivacaftor, a highly effective CFTR modulator therapy primarily utilized for gating mutations [10], was reported to improve CF-related chronic rhinosinusitis (CF CRC) symptoms in persons with medically and surgically intractable Cf CRC and has shown to improve food intake and appetite [11,12]. Here, CFTR is linked to colorectal carcinoma.